Literature DB >> 33513786

Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier.

Yelixza I Avila1, Morgan Chandler1, Edward Cedrone2, Hannah S Newton2, Melina Richardson1, Jie Xu2, Jeffrey D Clogston2, Neill J Liptrott3, Kirill A Afonin1, Marina A Dobrovolskaia2.   

Abstract

Recent insights into the immunostimulatory properties of n class="Chemical">nucleic acid nanoparticles (NANPs) have demonstrated that variations in the shape, size, and composition lead to distinct patterns in their immunostimulatory properties. While most of these studies have used a single lipid-based carrier to allow for NANPs' intracellular delivery, it is now apparent that the platform for delivery, which has historically been a hurdle for therapeutic nucleic acids, is an additional means to tailoring NANP immunorecognition. Here, the use of dendrimers for the delivery of NANPs is compared to the lipid-based platform and the differences in resulting cytokine induction are presented.

Entities:  

Keywords:  NANPs; cytokines; immunology; immunotherapies; nucleic acid nanoparticles; vaccines

Mesh:

Substances:

Year:  2021        PMID: 33513786      PMCID: PMC7865455          DOI: 10.3390/molecules26030652

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  63 in total

1.  PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy.

Authors:  Fereydoon Abedi-Gaballu; Gholamreza Dehghan; Maryam Ghaffari; Reza Yekta; Soheil Abbaspour-Ravasjani; Behzad Baradaran; Jafar Ezzati Nazhad Dolatabadi; Michael R Hamblin
Journal:  Appl Mater Today       Date:  2018-05-29

2.  Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial.

Authors:  Jonathan N Hofmann; Kai Yu; Rachel K Bagni; Qing Lan; Nathaniel Rothman; Mark P Purdue
Journal:  Cytokine       Date:  2011-07-20       Impact factor: 3.861

3.  Polyamidoamine dendrimers as gene delivery carriers in the inner ear: How to improve transfection efficiency.

Authors:  Hui Wang; Hai-Bo Shi; Shan-Kai Yin
Journal:  Exp Ther Med       Date:  2011-06-27       Impact factor: 2.447

Review 4.  Cytokine release: A workshop proceedings on the state-of-the-science, current challenges and future directions.

Authors:  Christine Grimaldi; Deborah Finco; Madeline M Fort; Daniel Gliddon; Kirsty Harper; Whitney S Helms; Jane A Mitchell; Raegan O'Lone; Stanley T Parish; Marie-Soleil Piche; Daniel M Reed; Gabriele Reichmann; Patricia C Ryan; Richard Stebbings; Mindi Walker
Journal:  Cytokine       Date:  2016-06-13       Impact factor: 3.861

5.  Cationic poly(amidoamine) dendrimer induces lysosomal apoptotic pathway at therapeutically relevant concentrations.

Authors:  Thommey P Thomas; Istvan Majoros; Alina Kotlyar; Douglas Mullen; Mark M Banaszak Holl; James R Baker
Journal:  Biomacromolecules       Date:  2009-12-14       Impact factor: 6.988

6.  DNA-Nanostructure-Gold-Nanorod Hybrids for Enhanced In Vivo Optoacoustic Imaging and Photothermal Therapy.

Authors:  Yang Du; Qiao Jiang; Nicolas Beziere; Linlin Song; Qian Zhang; Dong Peng; Chongwei Chi; Xin Yang; Hongbo Guo; Gaël Diot; Vasilis Ntziachristos; Baoquan Ding; Jie Tian
Journal:  Adv Mater       Date:  2016-09-28       Impact factor: 30.849

7.  Toll-Like Receptor-Mediated Recognition of Nucleic Acid Nanoparticles (NANPs) in Human Primary Blood Cells.

Authors:  Enping Hong; Justin R Halman; Ankit Shah; Edward Cedrone; Nguyen Truong; Kirill A Afonin; Marina A Dobrovolskaia
Journal:  Molecules       Date:  2019-03-20       Impact factor: 4.411

Review 8.  Smart-Responsive Nucleic Acid Nanoparticles (NANPs) with the Potential to Modulate Immune Behavior.

Authors:  Morgan Chandler; Kirill A Afonin
Journal:  Nanomaterials (Basel)       Date:  2019-04-12       Impact factor: 5.076

9.  RNA-DNA fibers and polygons with controlled immunorecognition activate RNAi, FRET and transcriptional regulation of NF-κB in human cells.

Authors:  Weina Ke; Enping Hong; Renata F Saito; Maria Cristina Rangel; Jian Wang; Mathias Viard; Melina Richardson; Emil F Khisamutdinov; Martin Panigaj; Nikolay V Dokholyan; Roger Chammas; Marina A Dobrovolskaia; Kirill A Afonin
Journal:  Nucleic Acids Res       Date:  2019-02-20       Impact factor: 16.971

10.  Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles.

Authors:  Emil F Khisamutdinov; Hui Li; Daniel L Jasinski; Jiao Chen; Jian Fu; Peixuan Guo
Journal:  Nucleic Acids Res       Date:  2014-08-04       Impact factor: 16.971

View more
  6 in total

1.  Anhydrous Nucleic Acid Nanoparticles for Storage and Handling at Broad Range of Temperatures.

Authors:  Allison N Tran; Morgan Chandler; Justin Halman; Damian Beasock; Adam Fessler; Riley Q McKeough; Phuong Anh Lam; Daniel P Furr; Jian Wang; Edward Cedrone; Marina A Dobrovolskaia; Nikolay V Dokholyan; Susan R Trammell; Kirill A Afonin
Journal:  Small       Date:  2022-02-06       Impact factor: 13.281

2.  The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field.

Authors:  Morgan Chandler; Brittany Johnson; Emil Khisamutdinov; Marina A Dobrovolskaia; Joanna Sztuba-Solinska; Aliasger K Salem; Koen Breyne; Roger Chammas; Nils G Walter; Lydia M Contreras; Peixuan Guo; Kirill A Afonin
Journal:  ACS Nano       Date:  2021-10-22       Impact factor: 18.027

Review 3.  Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs).

Authors:  Weina Ke; Kirill A Afonin
Journal:  Adv Drug Deliv Rev       Date:  2021-06-16       Impact factor: 17.873

4.  2021: an immunotherapy odyssey and the rise of nucleic acid nanotechnology.

Authors:  Martin Panigaj; Marina A Dobrovolskaia; Kirill A Afonin
Journal:  Nanomedicine (Lond)       Date:  2021-06-25       Impact factor: 6.096

Review 5.  Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation.

Authors:  Kirill A Afonin; Marina A Dobrovolskaia; Weina Ke; Piotr Grodzinski; Mark Bathe
Journal:  Adv Drug Deliv Rev       Date:  2021-12-13       Impact factor: 17.873

Review 6.  Current hurdles to the translation of nanomedicines from bench to the clinic.

Authors:  Snežana Đorđević; María Medel Gonzalez; Inmaculada Conejos-Sánchez; Barbara Carreira; Sabina Pozzi; Rita C Acúrcio; Ronit Satchi-Fainaro; Helena F Florindo; María J Vicent
Journal:  Drug Deliv Transl Res       Date:  2021-07-23       Impact factor: 4.617

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.